EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 37 / No 5 (Mai 2021) Med Sci (Paris), 37 5 (2021) 482-490 References
Open Access
Issue
Med Sci (Paris)
Volume 37, Number 5, Mai 2021
La révolution médicale du dépistage néonatal – Une aventure médicale scientifique et sociétale
Page(s) 482 - 490
Section La révolution médicale du dépistage néonatal – Une aventure médicale scientifique et sociétale
DOI https://doi.org/10.1051/medsci/2021056
Published online 18 May 2021
  1. Sundd P, Gladwin MT, Novelli EM. Pathophysiology of Sickle Cell Disease. Annu Rev Pathol 2019 ; 14 : 263–292. [Google Scholar]
  2. Ware RE, de Montalembert M, Tshilolo L. et al. Sickle cell disease. Lancet 2017 ; 390 : 311–323. [Google Scholar]
  3. Maier-Redelsperger M, Noguchi CT, de Montalembert M. et al. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease. Blood 1994 ; 84 : 3182–3188. [Google Scholar]
  4. Brousse V, Buffet P, Rees D. The spleen and sickle cell disease: the sick(led) spleen. Br J Haematol 2014 ; 166 : 165–176. [Google Scholar]
  5. Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 1968 ; 65 : 281–393. [Google Scholar]
  6. Grosse SD, Odame I, Atrash HK. et al. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med 2011 ; 41 : S398–S405. [Google Scholar]
  7. Lee A, Thomas P, Cupidore L. et al. Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ 1995 ; 311 : 1600–1602. [Google Scholar]
  8. Telfer P, Coen P, Chakravorty S. et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica 2007 ; 92 : 905–912. [Google Scholar]
  9. Quinn CT, Rogers ZR, McCavit TL. et al. Improved survival of children and adolescents with sickle cell disease. Blood 2010 ; 115 : 3447–3452. [Google Scholar]
  10. Desselas E, Thuret I, Kaguelidou F, et al. Mortality in children with sickle cell disease in mainland France from 2000 to 2015. Haematologica 2020, 105 :e440–e443. [Google Scholar]
  11. Couque N, Girard D, Ducrocq R. et al. Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines. Br J Haematol 2016 ; 173 : 927–937. [Google Scholar]
  12. Arrêté du 22 février 2018 relatif à l’organisation du programme national de dépistage néonatal recourant à des examens de biologie médicale. https://www.legifrance.gouv.fr/jorf/jo/2018/02/28/0049. [Google Scholar]
  13. Taylor SM, Parobek CM, Fairhurst RM. Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect Dis 2012 ; 12 : 457–468. [Google Scholar]
  14. Tsevat J, Wong JB, Pauker SG, Steinberg MH. Neonatal screening for sickle cell disease: a cost-effectiveness analysis. J Pediatr 1991 ; 118 : 546–554. [Google Scholar]
  15. Haute Autorité de Santé. Dépistage néonatal de la drépanocytose en France, rapport d’orientation. Saint-Denis: HAS, 2013. [Google Scholar]
  16. Programme National de Dépistage Néonatal. Rapport d’Activité 2019. http://depistage-neonatal.org/wp-content/uploads/2021/01/Rapport-Activite-2019.pdf. [Google Scholar]
  17. Lobitz S, Telfer P, Cela E. et al. Newborn screening for sickle cell disease in Europe: recommendations from a pan-European consensus conference. Br J Haematol 2018 ; 183 : 648–660. [Google Scholar]
  18. Detemmerman L, Olivier S, Bours V. et al. Innovative PCR without DNA extraction for African sickle cell disease diagnosis. Hematology 2018 ; 23 : 181–186. [Google Scholar]
  19. Cavazzana M, Stanislas A, Rémus C. et al. Dépistage néonatal de la drépanocytose : des données en faveur de sa généralisation. Med Sci (Paris) 2018 ; 34 : 309–311. [EDP Sciences] [Google Scholar]
  20. Allaf B, Patin F, Elion J. et al. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios. Pediat Blood Cancer 2018 ; 65 : e27230. [Google Scholar]
  21. Brousse V, Arnaud C, Lesprit E, et al. Evaluation of outcomes and quality of care in children with sickle cell disease diagnosed by newborn screening: a real-world nation-wide study in France. J Clin Med 2019; 8. [Google Scholar]
  22. Haute Autorité de Santé. Prise en charge de la drépanocytose chez l’enfant et l’adolescent. Paris: HAS, 2005. [Google Scholar]
  23. Lees C, Davies SC, Dezateux C. Neonatal screening for sickle cell disease. Cochrane Database Syst Rev 2000. doi.org/10.1002/14651858.CD001913 [Google Scholar]
  24. Gaston MH, Verter JI, Woods G. et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986 ; 314 : 1593–1599. [Google Scholar]
  25. Vichinsky E, Hurst D, Earles A. et al. Newborn screening for sickle cell disease: effect on mortality. Pediatrics 1988 ; 81 : 749–755. [Google Scholar]
  26. Streetly A, Sisodia R, Dick M. et al. Evaluation of newborn sickle cell screening programme in England: 2010–2016. Arch Dis Child 2018 ; 103 : 648–653. [Google Scholar]
  27. Oligbu G, Fallaha M, Pay L. et al. Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature. Br J Haematol 2019 ; 185 : 743–751. [Google Scholar]
  28. Bernaudin F, Verlhac S, Arnaud C. et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 2011 ; 117 : 1130–1140. [Google Scholar]
  29. Emond AM, Collis R, Darvill D. et al. Acute splenic sequestration in homozygous sickle cell disease: natural history and management. J Pediatr 1985 ; 107 : 201–206. [Google Scholar]
  30. Wang WC, Ware RE, Miller ST. et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet 2011 ; 377 : 1663–1672. [Google Scholar]
  31. Yawn BP, Buchanan GR, Afenyi-Annan AN. et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 2014 ; 312 : 1033–1048. [Google Scholar]
  32. Rémus C, Stanislas A, Bouazza N, et al. An evaluation of three ways of communicating carrier status results to the parents of children in a neonatal sickle cell screening programme. Front Pediatr 2020; 8 : 300. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.